MTSR

Metsera, Inc. - Common Stock (MTSR)

About Metsera, Inc. - Common Stock (MTSR)

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Details

Daily high

$22.02

Daily low

$19.77

Price at open

52 Week High

$32.81

52 Week Low

$12.30

Market cap

2.3B

Dividend yield

0.00%

Volume

629

Avg. volume

1.2M

P/E ratio

Metsera, Inc. - Common Stock News